• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.34%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.47 Up 0.03(2.08%) 2:20PM EDT - Nasdaq Real Time Price
    Prev Close:1.44
    Open:1.43
    Bid:1.45 x 10800
    Ask:1.47 x 200
    1y Target Est:3.92
    Beta:1.13284
    Earnings Date:Nov 2 - Nov 7 (Est.)
    Day's Range:1.43 - 1.47
    52wk Range:1.37 - 2.65
    Volume:45,635
    Avg Vol (3m):132,289
    Market Cap:104.53M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARQL

    Comparison

    Symbol% ChgMkt Cap
    ARQLUp 2.08%104.53M
    ARRYUp 1.10%464.80M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.33
    Quarterly EPS Est (Sep-16) :-0.09
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-0.93

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met recepto... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback